A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women.Published in:2018By:Schalkwijk, Stein;ter Heine, Rob;Colbers, Angela C.;Huitema, Alwin D. R.;Denti, Paolo;Dooley, Kelly E.;Capparelli, Edmund;Best, Brookie M.;Cressey, Tim R.;Greupink, Rick;Russel, Frans G. M.;Mirochnick, Mark;Burger, David M.Publication type:journal article